Amberjack Capital Partners, L.P. sold $143.6M of INVX (indirect holdings)

Amberjack Capital Partners, L.P. sold 5,000,000 indirectly-held shares of Innovex International, Inc. (INVX) at $28.71 ($143.55M total) across 6 trades on 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Amberjack Capital Partners, L.P.
Published Aug 10, 2026, 9:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$INVX
Neutral
medium confidence
Mentioned
$INVX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INVXNeutralLow
01

Why it matters

The disclosure provides concrete trade size, execution price, and post-sale holdings, which can influence short-term positioning and sentiment but does not by itself change company fundamentals.

02

Market read

A major holder reduced its INVX position by selling 5,000,000 shares at $28.71, with the filing noting a pre-arranged 10b5-1 plan.

03

What to watch

Traders should check whether other insiders or the company also disclosed contemporaneous actions (buybacks, financings, guidance) that could offset the sentiment impact.

Relevance 7/10Novelty 5/10Timing: filed on 2026-08-10, same day as the reported sale trades

Background

This is an SEC Form 4 insider transaction filed by Amberjack Capital Partners, L.P., a director and 10% owner, reporting an indirect open-market sale of Innovex International, Inc. shares.

Company-level read

Ticker impact

$INVXNeutralMedium confidence
Context

Amberjack Capital Partners, a 10% owner, filed a Form 4 showing an open-market sale of 5,000,000 INVX shares at $28.71 on 2026-08-10.

Expected impact

Likely modest, short-lived negative bias around the filing date; follow-through depends on broader tape and any concurrent company news.

Evidence & confidence

The filing discloses sale size, price, and that a pre-arranged 10b5-1 plan exists, which typically reduces the signal strength versus discretionary selling.

Market effects

No sector-level implications are stated; this is a single-issuer insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity management rather than bearish expectations, limiting downside follow-through.

Key entities

  • Innovex International, Inc.

    Subject of the Form 4, ticker INVX, where Amberjack reported a large open-market sale.

  • Amberjack Capital Partners, L.P.

    Reported as director and 10% owner, executing an indirect sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$INVXMedAI 8/10

Innovex (INVX) Q3 2026 Earnings Call Transcript

Innovex (INVX) reported Q3 2026 revenue of $265M, up 8% sequentially and 10% YoY, with adjusted EBITDA of $55M (21% margin). The company highlighted growth in North America, offshore, and Middle East, with new contracts in Venezuela and the North Sea. Innovex expects continued growth in 2027-2028, driven by subsea projects and market share gains. Free cash flow was $32M, 58% of adjusted EBITDA.

$INVXHigh

Innovex Announces Third Quarter 2026 Results

Innovex International, Inc. (INVX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Innovex Announces Third Quarter 2026 Results HOUSTON, October 29, 2026 – Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the third quarter of 2026. Third Quarter Highlights • Revenue of $265 million,

$INVXMedAI 8/10

Innovex (INVX) Q2 2026 Earnings Call Transcript

Innovex (INVX) reported Q2 2026 revenue of $245 million, up 2% sequentially and 9% year over year, with adjusted EBITDA of $48 million (20% margin) and free cash flow of $30 million. Management cited international/offshore growth and Mexico activity, plus a $95 million TCO Group acquisition completed July 1. Q3 guidance calls for $260 million to $270 million revenue and $51 million to $57 million adjusted EBITDA.

Med

Innovex International, Inc. Q2 2026 Earnings Call Summary

Innovex International, Inc. reported Q2 progress driven by higher international activity and subsea momentum, aided by integration of Dril-Quip and cross-selling. It acquired TCO Group, expecting Q3 2026 revenue of $15M and EBITDA of $3M from TCO. Middle East air freight added a $1.5M margin headwind. TCO was funded with $65M cash and $30M stock.